219 related articles for article (PubMed ID: 26589912)
1. Mathematical modeling reveals differential effects of erythropoietin on proliferation and lineage commitment of human hematopoietic progenitors in early erythroid culture.
Ward D; Carter D; Homer M; Marucci L; Gampel A
Haematologica; 2016 Mar; 101(3):286-96. PubMed ID: 26589912
[TBL] [Abstract][Full Text] [Related]
2. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
[TBL] [Abstract][Full Text] [Related]
3. Cooperative Effect of Erythropoietin and TGF-β Inhibition on Erythroid Development in Human Pluripotent Stem Cells.
Xie Y; Bai H; Liu Y; Hoyle DL; Cheng T; Wang ZZ
J Cell Biochem; 2015 Dec; 116(12):2735-43. PubMed ID: 26012423
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells.
Olweus J; Terstappen LW; Thompson PA; Lund-Johansen F
Blood; 1996 Sep; 88(5):1594-607. PubMed ID: 8781415
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
[TBL] [Abstract][Full Text] [Related]
6. MEIS1 regulates early erythroid and megakaryocytic cell fate.
Zeddies S; Jansen SB; di Summa F; Geerts D; Zwaginga JJ; van der Schoot CE; von Lindern M; Thijssen-Timmer DC
Haematologica; 2014 Oct; 99(10):1555-64. PubMed ID: 25107888
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
Lu J; Guo S; Ebert BL; Zhang H; Peng X; Bosco J; Pretz J; Schlanger R; Wang JY; Mak RH; Dombkowski DM; Preffer FI; Scadden DT; Golub TR
Dev Cell; 2008 Jun; 14(6):843-53. PubMed ID: 18539114
[TBL] [Abstract][Full Text] [Related]
8. The supportive effects of erythropoietin and mast cell growth factor on CD34+/CD36- sorted bone marrow cells of myelodysplasia patients.
Brada S; de Wolf J; Hendriks D; Esselink M; Ruiters M; Vellenga E
Blood; 1996 Jul; 88(2):505-10. PubMed ID: 8695798
[TBL] [Abstract][Full Text] [Related]
9. The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation.
Smith BW; Rozelle SS; Leung A; Ubellacker J; Parks A; Nah SK; French D; Gadue P; Monti S; Chui DH; Steinberg MH; Frelinger AL; Michelson AD; Theberge R; McComb ME; Costello CE; Kotton DN; Mostoslavsky G; Sherr DH; Murphy GJ
Blood; 2013 Jul; 122(3):376-85. PubMed ID: 23723449
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
11. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
[TBL] [Abstract][Full Text] [Related]
12. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
[TBL] [Abstract][Full Text] [Related]
13. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin-stimulated endothelial cells support erythroid cell differentiation of CD34(+) haematopoietic progenitors.
Zaid T; Frömmel C; Lun A; Moldenhauer A
Vox Sang; 2013 Oct; 105(3):253-8. PubMed ID: 23773054
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis.
Koh KR; Janz M; Mapara MY; Lemke B; Stirling D; Dörken B; Zenke M; Lentzsch S
Blood; 2005 May; 105(10):3833-40. PubMed ID: 15292067
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision.
Dalby A; Ballester-Beltrán J; Lincetto C; Mueller A; Foad N; Evans A; Baye J; Turro E; Moreau T; Tijssen MR; Ghevaert C
Stem Cell Reports; 2018 Dec; 11(6):1462-1478. PubMed ID: 30503262
[TBL] [Abstract][Full Text] [Related]
18. Parallel regulation of PKC-alpha and PKC-delta characterizes the occurrence of erythroid differentiation from human primary hematopoietic progenitors.
Lanuti P; Bertagnolo V; Gaspari AR; Ciccocioppo F; Pierdomenico L; Bascelli A; Sabatino G; Miscia S; Marchisio M
Exp Hematol; 2006 Dec; 34(12):1624-34. PubMed ID: 17157158
[TBL] [Abstract][Full Text] [Related]
19. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
